Details for 2019162585

Up to date per 02.04.2026

Actions

Title / Product Name

VERFAHREN ZUR VERBESSERUNG VON ASTHMASYMPTOMEN MIT BENRALIZUMAB

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2019162585

EP Publication Number

3536339

E-Number

1435664

Language

PCT Number

Publication Date

11.09.2019 A

06.10.2021 B1

Registration Date

06.10.2021

AT Publication Date

15.10.2021

Application Date

07.08.2014

Registration Number

Priorities

12.08.2013

201361864950 P

IPC

A61K 39/00 20060101AFI20190704BHEP

Maximum Duration of Protection

07.08.2034

Owner

Astrazeneca AB 151 85 SödertäljeSE

Representative

Häupl & Ellmeyer KG, PatentanwaltskanzleiMariahilfer Straße 50 (Eingang Kirchengasse 1)1070 WienAT

Inventor

WARD, ChristineMedImmune LLC One MedImmune Way Gaithersburg, Maryland 20878US

ROSKOS, LorinMedImmune LLC One MedImmune Way Gaithersburg, Maryland 20878US

WANG, BingMedImmune LLC One MedImmune Way Gaithersburg, Maryland 20878US

RAIBLE, Donald317 Lenape Drive Berwyn, Pennsylvania 19312US

Information about Fees